Projection of new active substance distribution by disease 1996-2020

Projected distribution of global available new active substances by disease type between 1996 and 2020*

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

November 2015



Survey time period

1996 to 2015

Supplementary notes

Note: Disease categories based on therapy areas and expected launches 2016-20. Orphan drugs are those to treat small populations with rare diseases, and are defined separately by U.S. FDA and the European Medicines Agency (EMA). Any medicine with an orphan designation for an approved use within the first year after global launch are categorized as Orphan. Half of designated orphan indications are granted more than a year after original approval.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry


About the region


Selected statistics


Other regions


Related statistics


Further related statistics

Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.